Weil Company’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
5,201
+631
| +14% | +$181K | 0.39% | 54 |
|
|
2025
Q1 | $1.41M | Buy |
4,570
+3,298
| +259% | +$1.02M | 0.42% | 46 |
|
|
2024
Q4 | $449K | Sell |
1,272
-10,531
| -89% | -$3.72M | 0.16% | 75 |
|
|
2024
Q3 | $4.23M | Sell |
11,803
-2,002
| -15% | -$717K | 1.39% | 18 |
|
|
2024
Q2 | $4.4M | Sell |
13,805
-775
| -5% | -$247K | 1.6% | 18 |
|
|
2024
Q1 | $3.35M | Sell |
14,580
-5,853
| -29% | -$1.34M | 1.33% | 22 |
|
|
2023
Q4 | $4.49M | Sell |
20,433
-27,587
| -57% | -$6.07M | 1.97% | 11 |
|
|
2023
Q3 | $10.8M | Sell |
48,020
-246
| -0.5% | -$55.6K | 5.39% | 3 |
|
|
2023
Q2 | $10.7M | Sell |
48,266
-148
| -0.3% | -$32.7K | 4.74% | 3 |
|
|
2023
Q1 | $10.8M | Buy |
48,414
+1,341
| +3% | +$300K | 4.92% | 3 |
|
|
2022
Q4 | $13.1M | Buy |
47,073
+6,616
| +16% | +$1.84M | 5.96% | 4 |
|
|
2022
Q3 | $8.47M | Buy |
40,457
+2,974
| +8% | +$623K | 5.2% | 3 |
|
|
2022
Q2 | $8.83M | Buy |
37,483
+2,152
| +6% | +$507K | 4.97% | 3 |
|
|
2022
Q1 | $6.34M | Buy |
35,331
+12,699
| +56% | +$2.28M | 3.19% | 4 |
|
|
2021
Q4 | $4.89M | Buy |
22,632
+10,031
| +80% | +$2.17M | 2.28% | 7 |
|
|
2021
Q3 | $2.33M | Buy |
12,601
+3,318
| +36% | +$612K | 1.21% | 22 |
|
|
2021
Q2 | $1.67M | Buy |
9,283
+1,816
| +24% | +$326K | 0.84% | 34 |
|
|
2021
Q1 | $1.25M | Buy |
+7,467
| New | +$1.25M | 0.71% | 37 |
|